company tower banner
Nanovetores Tecnologia S.A. Company Logo

Nanovetores Tecnologia S.A. NV Tranexamic Acid

NV Tranexamic Acid contains tranexamic acid encapsulated in lipid particles with particle diameter larger than 200nm. The blend encapsulation through the Nanovetores Technology allows the stabiliza- tion of sensitive components, therefore, complex of being formulated in their free form, providing Nano Tranexamic Acid a potent whitening action and is recommended for the treatment of melasma and for the prevention of UV-induced skin pigmentation.

INCI Name: Calendula Officinalis Flower Oil, Caprylyl Glycol, Glycyrrhiza Glabra (Licorice) Root Extract, Lauric Acid, Myristic Acid, Oleic Acid, PPG-15 Stearyl Ether, Phenoxyethanol, Poloxamer 407, Sodium Metabisulfite, Steareth-2, Steareth-21, Tocopheryl Acetate, Tranexamic Acid

Functions: Whitening Agent

Labeling Claims: Ulta Beauty's Conscious Beauty

Benefit Claims: Encapsulated Actives, Melanin Reduction, Pigmentation Reduction, Skin Whitening

  • TypeDocument Name
View All Documents

Knowde Enhanced TDS

Identification & Functionality

Carrier
Cosmetic Ingredients Functions

Features & Benefits

Benefits
  • Skin whitening
  • Assists in the treatment of melasma
Product Background

Melasma is an acquired chronic hypermelanosis, characterized by brownish macules in the skin's expo- sed areas, especially frontal and malar regions. It affects both sexes, with greater incidence in women, especially pregnant women. It occurs in all races, particularly in individuals with high skin phototypes, who live in areas with high rates of ultraviolet (UV) radiation. UV radiation is an important factor involved in the peroxidation of lipids in the cell membrane, with the release of free radicals, which would stimulate melanocytes. There are many factors involved in the etiology of the disease: genetic influences, exposu- re to UV radiation, pregnancy, hormonal therapies, cosmetics, sun-sensitizing drugs, endocrinopathies, stress, among others.

Tranexamic (trans-4-(Aminomethyl)cyclohexanecarboxylic) acid blocks the conversion of plasminogen (present in epidermal basal cells) into plasmin by inhibiting the plasminogen activator. This activator is responsible for the increased activity of melanocytes in vitro and blocking this effect may be the paracri- ne mechanism for reducing melasma hyperpigmentation. Thus, tranexamic acid has been studied as an effective alternative for the treatment of melasma.

Use Encapsulated Active Ingredients and Ensure
  • Stability Improvement
  • Use of sensitive active ingredients (without refrigeration)
  • Increased Solubility
  • Prolonged release
  • Increased effectiveness
  • Increased compability in the formulation
  • Occlusion of odors
  • Increased skin permeation
  • Reduced dose

Applications & Uses

Use Level
2.0 - 10.0
Usage
  • Anionic, nonionic and cationic emulsions
  • Anionic and nonionic polymers.

Properties

Physical Form
Appearance
Milky liquid colored Beige to Salmon
Odor
Characteristic
Typical Properties
ValueUnitsTest Method / Conditions
pH Stability3.0 - 7.0
pH Value5.0 - 7.0
Relative Density0.9 - 1.1g/ml
Dispersibility

Dispersion of encapsulated active ingredients in water.

Compatibility

The product has been tested in anionic, nonionic and cationic emulsions and with anionic and nonionic polymers, demonstrating compatibility with the tested bases. For water solutions of low viscosity, the use of a suspending agent or shaking before use is indicated.

Incompatibility

Enzymes, Sodium chloride, Ethanol and other Organic solvents.

Technical Details & Test Data

Nanovetores Encapsulation Technology

Nanovetores Tecnologia S.A. NV Tranexamic Acid - Nanovetores Encapsulation Technology

Multifunctional Lipid Particles that promote hydration and extended effect.

 

Nanovetores Tecnologia S.A. NV Tranexamic Acid - Nanovetores Encapsulation Technology - 1

Active Ingredient Protection against oxidation resulted from interaction with external environment and other components of the cosmetic formulation.

 

Nanovetores Tecnologia S.A. NV Tranexamic Acid - Nanovetores Encapsulation Technology - 2

Monodispersity, that ensures control of the particle size, providing adequate permeation to its proposed action.

 

Nanovetores Tecnologia S.A. NV Tranexamic Acid - Nanovetores Encapsulation Technology - 3

Secure particles larger than 200nm, biocompatible and biodegradable.

 

Nanovetores Tecnologia S.A. NV Tranexamic Acid - Nanovetores Encapsulation Technology - 4

Enzymatic Specific Release Trigger, where enzymes present on the skin disintegrate particles, releasing the active ingredient specifically where it needs to act.

 

Nanovetores Tecnologia S.A. NV Tranexamic Acid - Nanovetores Encapsulation Technology - 5

Greater Permeation on the contact surface due to the small size of the capsule.

 

Nanovetores Tecnologia S.A. NV Tranexamic Acid - Nanovetores Encapsulation Technology - 6

Surface Charge Control of the particle, promoting greater affinity with the contact surface.

 

Nanovetores Tecnologia S.A. NV Tranexamic Acid - Nanovetores Encapsulation Technology - 7

Water Base. Active ingredients are manufactured without the use of organic solvents, ensuring safety for users and the environment.

Storage & Handling

Storage

Keep in temperature between 20-25 °C.